Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2009. For permissions please email: journals.permissions@oxfordjournals.org.
The QRS interval in patients treated with resynchronization therapy: which value?
Institute of Cardiology, University of Bologna and Azienda Ospedaliera S.Orsola-Malpighi, Bologna, Italy
* Corresponding author: Tel: +39 059 349858, Fax: +39 051 344859, Email: giuseppe.boriani@unibo.it
This editorial refers to the paper entitled Surface electrocardiogram to predict outcome in candidates for cardiac resynchronisation therapy: a subanalysis of the CARE-HF trial
by Renaud Gervais et al., published on page 699
| The first 150 words of the full text of this article appear below. |
The electrocardiogram (ECG) was introduced into clinical practice more than 100 years ago and despite increased sophistication in diagnostic methods the 12-lead ECG remains an important reference step in patient evaluation today.
In heart failure (HF) patients, a simple 12-lead ECG provides important information that can be integrated with the clinical evaluation in order to predict patient outcome. In a cross-sectional analysis of HF patients, stratified according to New York Heart Association (NYHA) functional class, Stelbrink et al.1 reported that a more advanced NYHA class is associated with a more prolonged PR interval and a wider QRS interval. The relationship between ECG parameters and patient outcome was the subject of a series of longitudinal studies,2,3 which provided evidence that a wide QRS interval is associated with a worse prognosis, independently of the degree of left ventricular dysfunction.4,5 On the other hand, QRS duration is also an important predictor of the
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in Eur J Heart Fail:
- Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial
- Renaud Gervais, Christophe Leclercq, Aparna Shankar, Sandra Jacobs, Hans Eiskjær, Arne Johannessen, Nick Freemantle, John G.F. Cleland, Luigi Tavazzi, Claude Daubert, and on behalf of the CARE-HF investigators
Eur J Heart Fail 2009 11: 699-705.[Abstract] [Full Text]